Magnetically Enhanced Diffusion for Acute Ischaemic Stroke (MEDIS) Trial

A trial with no phase registered on ClinicalTrials.gov. The registry status is suspended. It plans to enroll 120 participants.

Also called NCT03098732

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; double masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 120 participants (planned count) (from the registry)
Sponsor
Pulse Therapeutics (from the registry)
Registry
  • NCT NCT03098732
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United Kingdom (from the registry)
Registry status
  • Suspended (from the registry)

Technical summary

Registry record NCT03098732. Randomized; double masking; primary purpose treatment. Start 2017-03-22 (actual); primary completion 2019-12-31 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Magnetically Enhanced Diffusion for Acute Ischaemic Stroke (MEDIS) Trial
Acronym
MEDIS
Condition
Stroke, Acute
Condition
Stroke, Ischemic
Condition
Infarction, Middle Cerebral Artery
Condition
Strokes Thrombotic
Condition
Neurologic Disorder
Condition
Cerebrovascular Disorders
Condition
Intracranial Embolism and Thrombosis
Intervention (Device)
Magnetically Enhanced Diffusion (MED)
Intervention (Device)
MED Workstation Magnet Sham Control
Lead sponsor
Pulse Therapeutics (class: industry)

Record details

Record id
cardio:ct-nct03098732
Content hash
294f3d8b9597b457fef0fb86f39fa7788cd4dfe5df974cec480aef3da3095764